ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer
Abroad (travel likely)RecruitingPHASE3
Conditions
Small Cell Lung Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beijing Cancer Hospital, Beijing, Beijing Municipality, China
Contact: Principal Investigator (Jian Fang)Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
Contact: Principal Investigator (Baogang Liu)Henan Cancer Hospital, Zhengzhou, Henan, China
Contact: Principal Investigator (Qiming Liu)Jilin Cancer Hospital, Changchun, Jilin, China
Contact: Principal Investigator (Ying Cheng)Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
Contact: Principal Investigator (Wei Zheng)Shandong Cancer Hospital, Jinan, Shandong, China
Contact: Principal Investigator (Haiyong Wang)Shanghai Pulmonary Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Peng Zhang)Contact: Principal Investigator (Peng Zhang)The First Affiliate Hospital of GUANGZHOU Medical University, Guangzhou, China
Contact: Principal Investigator (Ming Liu)Tongji Hospital, Wuhan, China
Contact: Principal Investigator (Qian Chu)